PMDA drug package insert
アルベカシン硫酸塩注射液25mg「ケミファ」
PMDA Prescription drug · シオノケミカル株式会社 · package insert Mar 25, 2026
Key facts
| Brand names | アルベカシン硫酸塩注射液25mg「ケミファ」, アルベカシン硫酸塩注射液75mg「ケミファ」, アルベカシン硫酸塩注射液100mg「ケミファ」, アルベカシン硫酸塩注射液200mg「ケミファ」 |
|---|---|
| Nonproprietary names | アルベカシン硫酸塩 |
| Companies | 製造販売元／シオノケミカル株式会社, 販売元／日本ケミファ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | アミノグリコシド系抗生物質製剤 |
| Therapeutic category codes | 876119 |
| YJ codes | 6119400A3070, 6119400A1107, 6119400A2103, 6119400A4068 |
| Approval numbers | 22200AMX01003000, 22200AMX01007000, 22200AMX01001000, 22200AMX01002000 |
| Package insert edition | 第2版 |
| Package insert date | Mar 25, 2026 |
| PMDA document key | 340409_6119400A1107_1 |
| PMDA company code | 340409 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: